Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-035574
Filing Date
2022-11-10
Accepted
2022-11-10 19:28:22
Documents
2
Period of Report
2022-11-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1470
2 EX-24 DOCUMENT attachment1.htm EX-24 3098
  Complete submission text file 0000899243-22-035574.txt   6009
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Issuer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
SWAIN SANDRA M (Reporting) CIK: 0001908755 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-32405 | Film No.: 221379140